All systems go for AFT Pharmaceuticals

All systems go for AFT Pharmaceuticals
Hartley Atkinson: negative economy won't impact growth. (Image: Supplied)
Brent Melville
AFT Pharmaceuticals expects to make inroads into the Australian market on the strength of its new Maxigesic sinus and pain treatment and hot drink sachet products.Product sales in Australia have steadily improved after the listed pharmaceutical group's successful legal appeal against British-based consumer products giant Reckitt Benckiser, allowing AFT to compare its products with paracetamol and ibuprofen in its advertising.That helped push overall product sales and royalties up by 30% during the half year to September 2022, though first-h...

More Markets

NZ sharemarket continues sliding, down 0.5%
Markets Market close

NZ sharemarket continues sliding, down 0.5%

The S&P/NZX 50 Index closed at 12,692.72, down 68.47 points or 0.54%.

Graham Skellern 12 Dec 2024
Spark sells remaining Connexa stake for $314m
Markets

Spark sells remaining Connexa stake for $314m

The sale will result in a $70m gain on telco's books.

Ben Moore 12 Dec 2024
Zespri on track for 'moderate increase' in volume next year
Primary Sector

Zespri on track for 'moderate increase' in volume next year

Zespri's producer vote to expand global supply passed this week.

Riley Kennedy 12 Dec 2024
Neal Barclay to exit Meridian as CEO
Markets

Neal Barclay to exit Meridian as CEO

Current CFO Mike Roan will take Barclay's spot atop Meridian.

Staff reporters 12 Dec 2024